Arrhythmias - Pipeline Review, H2 2018

Publisher Name :
Date: 07-Aug-2018
No. of pages: 52
Inquire Before Buying

Arrhythmias - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arrhythmias - Pipeline Review, H2 2018, provides an overview of the Arrhythmias (Cardiovascular) pipeline landscape.

An arrhythmia is a problem with the rate or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. Signs and symptoms include anxiety, weakness, dizziness, and light-headedness, fainting or nearly fainting, sweating, shortness of breath and chest pain. Treatment includes anti-arrhythmics and anticoagulants.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Arrhythmias - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Arrhythmias (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Arrhythmias (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arrhythmias and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Discovery stages are 1, 1, 9 and 2 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 1 molecules, respectively.

Arrhythmias (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Arrhythmias (Cardiovascular).

- The pipeline guide reviews pipeline therapeutics for Arrhythmias (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Arrhythmias (Cardiovascular) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Arrhythmias (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Arrhythmias (Cardiovascular)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Arrhythmias (Cardiovascular).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Arrhythmias (Cardiovascular) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Arrhythmias - Pipeline Review, H2 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Arrhythmias - Overview
Arrhythmias - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Arrhythmias - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Arrhythmias - Companies Involved in Therapeutics Development
Cynata Therapeutics Ltd
Gilead Sciences Inc
LATITUDE Pharmaceuticals Inc
Les Laboratoires Servier SAS
OMEICOS Therapeutics GmbH
Ono Pharmaceutical Co Ltd
Orion Corporation
SignPath Pharma Inc
Arrhythmias - Drug Profiles
amiodarone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Antisense Oligonucleotides to Activate hERG1 for Arrhythmias - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
efsevin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EU-8120 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GS-680 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GS-967 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KN-93 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
landiolol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
M-201 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
OMT-28 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ORM-10103 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PAM-4 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PP-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize RyR2 for Heart Failure and Arrhythmias - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Target FKBP1A for Cardiovascular Diseases - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SPP-4040 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Stem Cell Therapy for Asthma and Cardiovacular Diseases - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Arrhythmias - Dormant Projects
Arrhythmias - Discontinued Products
Arrhythmias - Product Development Milestones
Featured News & Press Releases
Sep 27, 2017: U.S. Patent Granted for Cynata Cymerus Technology
Sep 05, 2017: Cynata to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York
Apr 19, 2017: Cynata Advances to Pre-IND Meeting with US FDA
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Arrhythmias, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Arrhythmias - Pipeline by Cynata Therapeutics Ltd, H2 2018
Arrhythmias - Pipeline by Gilead Sciences Inc, H2 2018
Arrhythmias - Pipeline by LATITUDE Pharmaceuticals Inc, H2 2018
Arrhythmias - Pipeline by Les Laboratoires Servier SAS, H2 2018
Arrhythmias - Pipeline by OMEICOS Therapeutics GmbH, H2 2018
Arrhythmias - Pipeline by Ono Pharmaceutical Co Ltd, H2 2018
Arrhythmias - Pipeline by Orion Corporation, H2 2018
Arrhythmias - Pipeline by SignPath Pharma Inc, H2 2018
Arrhythmias - Dormant Projects, H2 2018
Arrhythmias - Discontinued Products, H2 2018

List of Figures
Number of Products under Development for Arrhythmias, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018
  • Global Pitavastatin Market Data Survey Report 2013-2025
    Published: 20-Apr-2019        Price: US 1500 Onwards        Pages: 60
    Summary Pitavastatin (usually as a calcium salt) is a member of the blood cholesterol lowering medication class of statins, marketed in the United States under the trade name Livalo, and in European Union and Russia under the trade name Livazo. Like other statins, it is an inhibitor of HMG-CoA reductase, the enzyme that catalyses the first step of cholesterol synthesis. The global Pitavastatin market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main conte......
  • Global Digoxin Market Insights, Forecast to 2025
    Published: 18-Apr-2019        Price: US 3900 Onwards        Pages: 113
    Global Digoxin market size will increase to Million US$ by 2025, from Million US$ in 2018, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Digoxin. This report researches the worldwide Digoxin market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions. This study cate......
  • Global Cilostazol Market Insights, Forecast to 2025
    Published: 16-Apr-2019        Price: US 3900 Onwards        Pages: 127
    The global Cilostazol market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cilostazol market based on company, product type, end user and key regions. This report studies the global market size of Cilostazol in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the c......
  • Global (United States, European Union and China) Congestive Heart Failure Drugs Market Research Report 2019-2025
    Published: 15-Apr-2019        Price: US 3280 Onwards        Pages: 121
    In 2019, the market size of Congestive Heart Failure Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Congestive Heart Failure Drugs. This report studies th......
  • Global Simvastatin Market Data Survey Report 2013-2025
    Published: 14-Apr-2019        Price: US 1500 Onwards        Pages: 64
    Summary The global Simvastatin market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major Application Global market size by Major Type Key manufacturers are included based on company profile, sal......
  • Global Myocardial Ischemia Drugs Market Research Report 2019
    Published: 12-Apr-2019        Price: US 2900 Onwards        Pages: 94
    The global Myocardial Ischemia Drugs market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Myocardial Ischemia Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Myocardial Ischemia Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key region......
  • Global Eptifibatide Market Growth 2019-2024
    Published: 09-Apr-2019        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Eptifibatide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Eptifibatide business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Eptifibatide market by product type, applica......
  • Global Simvastatin Market Insights, Forecast to 2025
    Published: 09-Apr-2019        Price: US 3900 Onwards        Pages: 122
    The global Simvastatin market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Simvastatin market based on company, product type, end user and key regions. This report studies the global market size of Simvastatin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on th......
  • Global Eptifibatide Market Insights, Forecast to 2025
    Published: 09-Apr-2019        Price: US 3900 Onwards        Pages: 112
    The global Eptifibatide market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Eptifibatide market based on company, product type, end user and key regions. This report studies the global market size of Eptifibatide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs